Focus on the glycerophosphocholine pathway in choline phospholipid metabolism of cancer
Activated choline metabolism is a hallmark of carcinogenesis and tumor progression, which
leads to elevated levels of phosphocholine and glycerophosphocholine in all types of …
leads to elevated levels of phosphocholine and glycerophosphocholine in all types of …
[HTML][HTML] Phospholipase A2 Drives Tumorigenesis and Cancer Aggressiveness through Its Interaction with Annexin A1
L Vecchi, TG Araujo, FVPV Azevedo, STS Mota… - Cells, 2021 - mdpi.com
Phospholipids are suggested to drive tumorigenesis through their essential role in
inflammation. Phospholipase A2 (PLA2) is a phospholipid metabolizing enzyme that …
inflammation. Phospholipase A2 (PLA2) is a phospholipid metabolizing enzyme that …
Nanoaggregate probe for breast cancer metastasis through multispectral optoacoustic tomography and aggregation‐induced NIR‐I/II fluorescence imaging
J Ouyang, L Sun, Z Zeng, C Zeng, F Zeng… - Angewandte …, 2020 - Wiley Online Library
An activatable nanoprobe for imaging breast cancer metastases through near infrared‐I
(NIR‐I)/NIR‐II fluorescence imaging and multispectral optoacoustic tomography (MSOT) …
(NIR‐I)/NIR‐II fluorescence imaging and multispectral optoacoustic tomography (MSOT) …
[HTML][HTML] Annexin10 promotes extrahepatic cholangiocarcinoma metastasis by facilitating EMT via PLA2G4A/PGE2/STAT3 pathway
R Sun, Z Liu, B Qiu, T Chen, Z Li, X Zhang, Y Xu… - …, 2019 - thelancet.com
Background Cholangiocarcinoma (CCA), consisting of intrahepatic (IHCCA), perihilar
(PHCCA), and distal (DCCA) CCA, is a type of highly aggressive malignancy with a very …
(PHCCA), and distal (DCCA) CCA, is a type of highly aggressive malignancy with a very …
[HTML][HTML] Human plasma metabolomics for identifying differential metabolites and predicting molecular subtypes of breast cancer
Purpose This work aims to identify differential metabolites and predicting molecular
subtypes of breast cancer (BC). Methods Plasma samples were collected from 96 BC …
subtypes of breast cancer (BC). Methods Plasma samples were collected from 96 BC …
FADS2 function at the major cancer hotspot 11q13 locus alters fatty acid metabolism in cancer
KSD Kothapalli, HG Park, NSL Kothapalli… - Progress in Lipid …, 2023 - Elsevier
Dysregulation of fatty acid metabolism and de novo lipogenesis is a key driver of several
cancer types through highly unsaturated fatty acid (HUFA) signaling precursors such as …
cancer types through highly unsaturated fatty acid (HUFA) signaling precursors such as …
[HTML][HTML] BAG3 overexpression and cytoprotective autophagy mediate apoptosis resistance in chemoresistant breast cancer cells
Target-specific treatment modalities are currently not available for triple-negative breast
cancer (TNBC), and acquired chemotherapy resistance is a primary obstacle for the …
cancer (TNBC), and acquired chemotherapy resistance is a primary obstacle for the …
[HTML][HTML] Human plasma metabolomics for biomarker discovery: Targeting the molecular subtypes in breast cancer
L Díaz-Beltrán, C González-Olmedo, N Luque-Caro… - Cancers, 2021 - mdpi.com
Simple Summary Breast cancer is the leading cause of female cancer-related deaths
worldwide. New technologies with enhanced sensitivity and specificity for early diagnosis …
worldwide. New technologies with enhanced sensitivity and specificity for early diagnosis …
Phospholipase A2 inhibitors for the treatment of inflammatory diseases: a patent review (2010 – present)
V Magrioti, G Kokotos - Expert Opinion on Therapeutic Patents, 2013 - Taylor & Francis
Introduction: Phospholipases A2 have been implicated in various pathological conditions,
such as rheumatoid arthritis, cardiovascular diseases, neurological disorders and cancer …
such as rheumatoid arthritis, cardiovascular diseases, neurological disorders and cancer …
EGFR TKI resistance in lung cancer cells using RNA sequencing and analytical bioinformatics tools
MC Howell Jr, R Green, J Cianne… - Journal of …, 2023 - Taylor & Francis
Abstract Epidermal Growth Factor Receptor (EGFR) signaling and EGFR mutations play key
roles in cancer pathogenesis, particularly in the development of drug resistance. For the∼ …
roles in cancer pathogenesis, particularly in the development of drug resistance. For the∼ …